News
After years of development, Isomorphic Labs says its AI-created drugs are nearly ready for human trials. Isomorphic Labs, the ...
A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...
Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...
Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.
The company was spun out of Google DeepMind in 2021, and is built on the breakthrough AlphaFold system, an AI model that ...
Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...
Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...
Google DeepMind's Isomorphic Labs is set to begin human trials of drugs designed by artificial intelligence, marking a ...
Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...
The new system improved one model's diagnostic accuracy to 85% - but AI probably won't replace your doctor just yet.
Pathos AI Inc., a startup using artificial intelligence to develop new oncology drugs, today announced that it has raised $365 million in a late-stage funding.. The company didn’t disclose the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results